Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

09:30
10/13/16
10/13
09:30
10/13/16
09:30

Bristol-Myers downgraded to Buy from Conviction Buy at Goldman

Goldman analyst Jami Rubin removed Bristol-Myers from the Conviction Buy List and lowered its price target to $67 from $75 saying disappointing CM-26 data adds a greater level of uncertainty to future trials. He continues to believe is well positioned for 2017, and view the shares as very attractive over the long-term.

  • 27

    Oct

  • 31

    Oct

  • 06

    Nov

BMY Bristol-Myers

09/20/16
SBSH
09/20/16
NO CHANGE
Target $70
SBSH
Buy
Bristol-Myers price target lowered to $70 from $75 at Citi
In a research note titled "Brace Yourself. Attractive Valuation but No Near-Term Respite.," Citi analyst Andrew Baum lowered his price target for shares of Bristol-Myers Squibb to $70 from $75. The analyst lowered his earnings forecasts by up to 8% to reflect the "limited supportive data" in the non-small cell lung cancer indication. Baum keeps a Buy rating on the shares as he views the valuation as attractive. He points out, however, the near-term news-flow is likely to be negative.
09/27/16
PIPR
09/27/16
NO CHANGE
Target $62
PIPR
Neutral
Bristol-Myers price target lowered to $62 from $65 at Piper Jaffray
Piper Jaffray analyst Richard Purkiss lowered his price target for Bristol-Myers Squibb (BMY) to $62 saying he sees the company ceding Opdivo's early-mover advantage in lung cancer to competitors. The analyst expects to see details from Roche's (RHHBY) positive OAK trial of Tecentriq vs. docetaxel in non-small cell lung cancer at the upcoming ESMO meeting. Purkiss also expects to see details from Merck's (MRK) positive KEYNOTE-024 trial of Keytruda. The analyst lowered his post-2016 Opdivo forecasts and reiterates a Neutral rating on Bristol shares.
09/28/16
ROTH
09/28/16
NO CHANGE
Target $23
ROTH
Buy
Nektar price target raised to $23 from $19 at Roth Capital
Roth Capital analyst Michael Higgins raised his price target for Nektar (NKTR) to $23 from $19 after the company and Bristol-Myers (BMY) announced a clinical collaboration to evaluate the combination of the latter's anti-PD-1 antibody, Opdivo, with NKTR-214. The analyst reiterates a Buy rating on Nektar's shares.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink sees Bristol-Myers sliding after Merck's 'spectacular' Keytruda data
Leerink analyst Seamus Fernandez said Bristol-Myers' (BMY) Checkmate-026 data presented at the European Society of Medical Oncology meeting was disappointing, noting there was no signal of benefit on progression-free survival or overall survival and only "modest differentiation" on response rate in the 88 patients with PDL1 biomarker positivity greater than or equal to 50%. Meanwhile, Merck (MRK) presented "spectacular" data for Keytruda monotherapy at the meeting, said Fernandez, who expects Bristol shares to be down "significantly" today in light of the meeting presentations. The analyst, who still thinks Bristol has a significant opportunity to compete with Merck's Keytruda in the PDL1 high portion of the market, keeps an Outperform rating on Bristol shares, which are down nearly 6% in pre-market trading.

TODAY'S FREE FLY STORIES

11:37
04/26/17
04/26
11:37
04/26/17
11:37
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:36
04/26/17
04/26
11:36
04/26/17
11:36
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

NADL

North Atlantic Drilling

$2.43

0.23 (10.45%)

11:34
04/26/17
04/26
11:34
04/26/17
11:34
Hot Stocks
North Atlantic Drilling jumps 12% after credit facility amended »

Earlier today, North…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWW

Grainger

$192.85

-0.51 (-0.26%)

11:31
04/26/17
04/26
11:31
04/26/17
11:31
Hot Stocks
Grainger raises dividend 5% to $1.28 per share »

W.W. Grainger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 19

    Jul

  • 17

    Oct

  • 24

    Jan

FCAU

Fiat Chrysler

$11.48

0.94 (8.92%)

11:31
04/26/17
04/26
11:31
04/26/17
11:31
Options
Fiat Chrysler option volume is 7X normal driven by a premium sale »

Fiat Chrysler option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$32.33

0.47 (1.48%)

, EVR

Evercore Partners

$75.30

-3.5 (-4.44%)

11:25
04/26/17
04/26
11:25
04/26/17
11:25
Periodicals
Volkswagen considering options for Ducati motorcycle brand, Reuters reports »

Volkswagen (VLKAY) has…

VLKAY

Volkswagen

$32.33

0.47 (1.48%)

EVR

Evercore Partners

$75.30

-3.5 (-4.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

INFO

IHS Markit

$43.76

-0.05 (-0.11%)

11:25
04/26/17
04/26
11:25
04/26/17
11:25
Conference/Events
IHS Markit to hold an investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

CGIX

Cancer Genetics

$4.15

-0.05 (-1.19%)

, TRPX

Therapix Biosciences

$7.30

-0.2 (-2.67%)

11:25
04/26/17
04/26
11:25
04/26/17
11:25
Conference/Events
RedChip to hold a virtual conference »

April Global Online…

CGIX

Cancer Genetics

$4.15

-0.05 (-1.19%)

TRPX

Therapix Biosciences

$7.30

-0.2 (-2.67%)

PBIO

Pressure BioSciences

$0.26

-0.03055 (-10.54%)

IDXG

Interpace Diagnostics

$2.43

0.09 (3.85%)

XRM

Xerium Technologies

$6.97

0.08 (1.16%)

ESES

Eco-Stim Energy

$1.09

-0.0001 (-0.01%)

AMMA

Alliance MMA

$1.40

-0.14 (-9.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 01

    May

TRN

Trinity Industries

$27.60

0.84 (3.14%)

11:22
04/26/17
04/26
11:22
04/26/17
11:22
Hot Stocks
Trinity sees Q2 revenue for Inland Barge running at approx. 50% of Q1 levels »

Says "very little…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 01

    May

  • 09

    May

LN

LINE Corp.

$34.72

-2.8654 (-7.62%)

11:22
04/26/17
04/26
11:22
04/26/17
11:22
Downgrade
LINE Corp. rating change  »

Update: LINE Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$37.10

-0.115 (-0.31%)

11:21
04/26/17
04/26
11:21
04/26/17
11:21
Options
Defensive option play opened in the Brazil ETF »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
04/26/17
04/26
11:17
04/26/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GGP

GGP

$22.36

-0.25 (-1.11%)

11:16
04/26/17
04/26
11:16
04/26/17
11:16
Options
General Growth put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 17

    May

$NYE

NYSE Market Internals

11:16
04/26/17
04/26
11:16
04/26/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LN

LINE Corp.

$34.75

-2.84 (-7.56%)

11:15
04/26/17
04/26
11:15
04/26/17
11:15
Downgrade
LINE Corp. rating change  »

LINE Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$485.52

13.7602 (2.92%)

11:10
04/26/17
04/26
11:10
04/26/17
11:10
Hot Stocks
Battleground: Piper says buy Chipotle after earnings while RBC steps aside »

Shares of Chipotle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$180.73

-2.78 (-1.51%)

11:04
04/26/17
04/26
11:04
04/26/17
11:04
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing sees organic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 31

    May

MDSO

Medidata

$63.34

-0.31 (-0.49%)

11:02
04/26/17
04/26
11:02
04/26/17
11:02
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

NUS

Nu Skin

$56.59

-0.52 (-0.91%)

11:02
04/26/17
04/26
11:02
04/26/17
11:02
Downgrade
Nu Skin rating change  »

Nu Skin downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 20

    Jun

AHL

Aspen Insurance

$51.83

0.325 (0.63%)

11:01
04/26/17
04/26
11:01
04/26/17
11:01
Hot Stocks
Aspen Insurance raises quarterly dividend 9.1% to 24c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

FSLR

First Solar

$27.54

0.46 (1.70%)

11:01
04/26/17
04/26
11:01
04/26/17
11:01
Options
Size call buying spikes shares in First Solar »

Size call buying spikes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 17

    May

HSII

Heidrick & Struggles

$22.00

-4.75 (-17.76%)

11:01
04/26/17
04/26
11:01
04/26/17
11:01
Recommendations
Heidrick & Struggles analyst commentary  »

Heidrick & Struggles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

11:00
04/26/17
04/26
11:00
04/26/17
11:00
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

BA

Boeing

$180.93

-2.58 (-1.41%)

10:59
04/26/17
04/26
10:59
04/26/17
10:59
Hot Stocks
Breaking Hot Stocks news story on Boeing »

Boeing sees Defense as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 31

    May

EA

Electronic Arts

$92.99

0.18 (0.19%)

, ATVI

Activision Blizzard

$51.36

0.48 (0.94%)

10:57
04/26/17
04/26
10:57
04/26/17
10:57
Hot Stocks
Analyst sees video game makers boosted by continued shift to digital »

Pacific Crest analyst…

EA

Electronic Arts

$92.99

0.18 (0.19%)

ATVI

Activision Blizzard

$51.36

0.48 (0.94%)

TTWO

Take-Two

$62.63

0.08 (0.13%)

GME

GameStop

$23.70

0.3 (1.28%)

NTDOY

Nintendo

$31.65

0.55 (1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 09

    May

  • 23

    May

  • 31

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.